Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN )

1.025 +0.645 (+170.02%)
Streaming Delayed Price Updated: 1:16 PM EDT, Oct 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 213,604,482
Open 0.8551
Bid (Size) 1.020 (346)
Ask (Size) 1.030 (130)
Prev. Close 0.3796
Today's Range 0.7426 - 1.310
52wk Range 0.2556 - 21.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-89.75%
-89.75%
1 Month
+113.99%
+113.99%
3 Month
+44.39%
+44.39%
6 Month
-56.38%
-56.38%
1 Year
-89.75%
-89.75%

More News

Read More
Leaders in The News: BigBear.ai, Luminar, New World Solutions, Tevogen Bio
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
A Lot Of Home Runs And One Ugly Strikeout; One New Swing Position
Via Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Tevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long COVID Patients and Highlights Achievements and Assets as a Blueprint for Biotech Innovation
From Tevogen Bio Inc
Via GlobeNewswire
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tevogen Bio Secures $6 Million Series C Preferred Stock Investment
From Tevogen Bio Inc
Via GlobeNewswire
CORRECTION – Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s Innovation and Public Health Advisory Board Chairperson, Professor Sten Vermund, Appointed Dean of the University of South Florida Health College of Public Health
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s Founding CEO, Ryan Saadi, Expresses Conviction in Company’s Growth Strategy and Reaffirms Newly Effective Form S-1 Does Not Relate to Previously Undisclosed New Issuance of Dilutive Securities
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
From Tevogen Bio Inc
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.